The California Emerging Therapies Research Partnership Act.
Vote required
Two Thirds
Fiscal committee
No
Appropriation
No
Current location
Appropriations
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed Assembly
- To Governor
- Became Law
Overview
This bill, the California Emerging Therapies Research Partnership Act, creates a state fund to support research into emerging therapies like psilocybin and ketamine, primarily for clinical trials. It aims to secure federal funding through a partnership with the Advanced Research Projects Agency for Health (ARPA-H). The fund will be administered by the Department of Health Care Services and the Department of Veterans Affairs, and it will focus on University of California-led research, particularly for veterans struggling with conditions like PTSD and depression. The bill also outlines procedures for applying for and managing this federal partnership, including data sharing agreements and reporting requirements to the legislature.
Key provisions
- Establishes the California Emerging Therapies Research Partnership Fund, a continuously appropriated state fund.
- Defines ‘emerging therapies’ for the purposes of the fund (psilocybin, ibogaine, dimethyltryptamine, ketamine in clinical trials).
- Requires the California Health and Human Services Agency to apply for ARPA-H partnership designation.
- Mandates data-sharing agreements with federal agencies to facilitate clinical trial data exchange.
- Requires the Department of Veterans Affairs to convene an advisory council to guide research efforts.
- Authorizes the submission of a federal readiness report to the legislature by January 1, 2028.
- Allows home protection companies to offer cash payments in lieu of repairs or replacements under certain circumstances.
- Prohibits the use of fund moneys for purchasing, distributing, or administering controlled substances.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
6 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours